Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Lantern Pharma has had the opportunity to host several Key Opinion Leader webinars with world-renowned experts in various fields of oncology and drug discovery. Click on the links below to learn more.
From Discovery to Clinical Trials to Patients: Key Decisions Shaping Novel CNS Oncology Medicines
Lantern Pharma CEO Panna Sharma sits down with newly appointed Board Member Dr. Lee Schalop — co-founder of Oncoceutics and one of the leaders behind the development of ONC201 (Dordaviprone) — for a thoughtful discussion on the future of CNS oncology drug development.
